Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 8/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 3/20 | 1.00 |
| ▸ | HTR2B | P41595 | 1/20 | 1.00 |
| ▸ | NR3C1 | P04150 | 8/20 | 0.71 |
| ▸ | HIF1A | Q16665 | 7/20 | 0.71 |
| ▸ | AR | P10275 | 7/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.71 |
| ▸ | LMNA | P02545 | 3/20 | 0.71 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.71 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.62 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | RAB9A | P51151 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diflucortolone SCHEMBL3796 | 1.00 | PGR (1.00) | PGRNR1I2HTR2BNR3C1HIF1A | |
| Diflucortolone SCHEMBL11338795 | 1.00 | PGR (1.00) | PGRNR1I2HTR2BNR3C1HIF1A | |
| Diflucortolone SCHEMBL5484149 | 1.00 | PGR (1.00) | PGRNR1I2HTR2BNR3C1HIF1A | |
| Diflucortolone SCHEMBL11856229 | 1.00 | PGR (1.00) | PGRNR1I2HTR2BNR3C1HIF1A | |
| Diflucortolone SCHEMBL3795 | 1.00 | PGR (1.00) | PGRNR1I2HTR2BNR3C1HIF1A | |
| Diflucortolone SCHEMBL11855200 | 1.00 | PGR (1.00) | PGRNR1I2HTR2BNR3C1HIF1A | |
| Diflucortolone SCHEMBL10052991 | 1.00 | PGR (1.00) | PGRNR1I2HTR2BNR3C1HIF1A | |
| Diflucortolone SCHEMBL22040571 | 1.00 | PGR (1.00) | PGRNR1I2HTR2BNR3C1HIF1A | |
| Diflucortolone SCHEMBL22039899 | 1.00 | PGR (1.00) | PGRNR1I2HTR2BNR3C1HIF1A | |
| Diflucortolone SCHEMBL5484155 | 1.00 | PGR (1.00) | PGRNR1I2HTR2BNR3C1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8072 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4683679-A1 | METHOD FOR DIAGNOSING AND TREATING NIS-EXPRESSING CARCINOMAS AND METASTASES | NUSKE, Andreas (DE) | 2026-01-28 | — | — | EP | claimed |
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| US-20250213544-A1 | ALK5 INHIBITORS AS SKELETAL MUSCLE HYPERTROPHY INDUCERS | CYTOO (FR) | 2025-07-03 | — | — | US | claimed |
| US-20250205227-A1 | METHODS FOR ADMINISTERING CORTICOSTEROIDS | SPARROW PHARMACEUTICALS, INC. | 2025-06-26 | — | — | US | claimed |
| WO-2025123147-A1 | TOLERIZING IMMUNOMODULATORY COMBINATION | INTEGRATED NANOTHERAPEUTICS INC. (CA) | 2025-06-19 | — | — | WO | claimed |
| CN-120154586-A | Powder aerosol composition for inhalation, powder aerosol for inhalation, preparation method of powder aerosol for inhalation and powder aerosol for inhalation | 上海臣邦医药科技股份有限公司 | 2025-06-17 | — | — | CN | claimed |
| US-12303498-B2 | ALK5 inhibitors as skeletal muscle hypertrophy inducers | CYTOO (FR) | 2025-05-20 | — | — | US | claimed |
| US-12296043-B2 | Liquisoft capsules | PATHEON SOFTGELS INC. (US) | 2025-05-13 | — | — | US | claimed |
| US-20250144021-A1 | GEL FORMULATIONS FOR LOCAL DRUG RELEASE | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2025-05-08 | — | — | US | claimed |
| WO-2025076059-A1 | ROCAGLATE DERIVATIVES AND USES THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2025-04-10 | — | — | WO | claimed |
| WO-1996012487-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1996012817-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| US-5407663-A | Swishing solution in mouth, expectorating | EISEN DRORE (US) | 1995-04-18 | — | — | US | claimed |
| US-5387583-A | Advances protective regulation of immune system without giving rise to side effects | LORIA, ROGER M. | 1995-02-07 | — | — | US | claimed |
| WO-1994023722-A1 | HYDROCORTISONE BUFFERING ACTIVITY | LORIA ROGER M (US) | 1994-10-27 | — | — | WO | claimed |
| US-5310545-A | Method of treatment using mouthwashes containing steroids and antifungal agents and compositions of matter | EISEN DRORE | 1994-05-10 | — | — | US | claimed |
| EP-0173478-B1 | Treatment of skin disorders | SCOTIA HOLDINGS PLC (GB) | 1994-02-02 | — | — | EP | claimed |
| EP-0496520-A1 | Novel bone acting agents | MERCK & CO. INC. (US) | 1992-07-29 | — | — | EP | claimed |
| EP-0173478-A1 | Treatment of skin disorders | SCOTIA HOLDINGS PLC (GB) | 1986-03-05 | — | — | EP | claimed |
| EP-0068553-B1 | TOPICAL ANTIMICROBIAL ANTI-INFLAMMATORY COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1985-11-21 | — | — | EP | claimed |